72X

MicroPort CardioFlow Medtech Co., Ltd. (72X)

Market Open
9 Dec, 07:08
XFRA XFRA
0. 12
-0
-3.31%
278.43M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
0.12
Previous Close
Day Range
0.12 0.12
Year Range
0.04 0.17
Want to track 72X and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

72X trading today lower at €0.12, a decrease of 3.31% from yesterday's close, completing a monthly decrease of -7.14% or €0.01. Over the past 12 months, 72X stock gained 181.93%.
72X is not paying dividends to its shareholders.
The last earnings report, released on Aug 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

72X Chart

Similar

HQ1
Oruka Therapeutics, Inc.
-
-
957
Digital Hearts Holdings Co., Ltd.
12.6
0%
BioInvent International AB
2.61
+1.16%
2N3
Lna Santé S.A.
22.8
+0.88%
25E
Elan Corporation plc
3.72
-0.53%

MicroPort CardioFlow Medtech Co., Ltd. (72X) FAQ

What is the stock price today?

The current price is €0.12.

On which exchange is it traded?

MicroPort CardioFlow Medtech Co., Ltd. is listed on XFRA.

What is its stock symbol?

The ticker symbol is 72X.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 278.43M.

Has MicroPort CardioFlow Medtech Co., Ltd. ever had a stock split?

No, there has never been a stock split.

MicroPort CardioFlow Medtech Co., Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Jeffrey R Lindstrom CEO
XFRA Exchange
KYG6082P1054 ISIN
DE Country
483 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

MicroPort CardioFlow Medtech Corporation stands at the forefront of medical innovation, dedicated to the design, development, and global distribution of cutting-edge devices aimed at treating structural heart diseases. Founded in 2010 and based in Shanghai, China, the company has rapidly expanded its footprint beyond its domestic borders, showcasing a robust commitment to improving patient outcomes worldwide. With a clear focus on transcatheter and surgical heart solutions, MicroPort CardioFlow is carving out a significant niche in the medical device industry.

Products and Services

Vitaflow Aortic Valve System
This flagship product represents a leap forward in the treatment of aortic valve stenosis, a condition characterized by the narrowing of the aortic valve opening. The Vitaflow Aortic Valve System employs a minimally invasive approach, employing transcatheter technology to replace the diseased valve without the need for open-heart surgery, thereby reducing recovery times and improving patient outcomes.

Alwide Balloon Catheter
Designed for use in cardiac procedures, this specialized balloon catheter facilitates the dilation of blood vessels or the heart valve, ensuring improved blood flow and heart function. Its design and construction cater specifically to the challenges of cardiovascular interventions, offering precision and reliability to healthcare professionals.

Alpass Introducer Set
This comprehensive kit is essential for clinicians performing minimally invasive cardiac procedures, such as transcatheter aortic valve replacement (TAVR). It provides all necessary tools for the safe and effective introduction of catheters and other devices into the bloodstream, minimizing the risk of complications and streamlining the procedural workflow.

Angelguide Tip-Preshaped Super Stiff Guidewire
Precision and control are paramount in navigating the vascular system during complex interventions. The Angelguide offers unrivaled steerability and stiffness, enabling clinicians to reach target areas with confidence and accuracy. This guidewire is a critical component in procedures requiring the utmost in maneuverability and support.

Mitral, Tricuspid, and Surgical Valves
MicroPort CardioFlow's portfolio extends into surgical solutions with its range of mitral and tricuspid valves, alongside other surgical valve options. These devices are designed for implantation in cases where transcatheter solutions are not viable, ensuring that patients have access to life-saving interventions regardless of their specific medical needs.

Procedural Accessories
Recognizing the importance of supporting healthcare professionals in their work, MicroPort CardioFlow offers an extensive array of procedural accessories. These products are engineered to facilitate a variety of cardiovascular interventions, underscoring the company's commitment to full-spectrum support in cardiac care.

Technical Consultation and Clinical Trial Support
Beyond manufacturing state-of-the-art medical devices, MicroPort CardioFlow Medtech Corporation provides vital consulting services and support for clinical trials of medical devices. This service allows for the optimization of clinical testing and the swift introduction of innovative medical solutions to the market, furthering the advancement of medical science in the cardiac domain.

Contact Information

Address: No. 1661 Zhangdong Road, Shanghai, China, 201203
Phone: 86 21 3895 4600